Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Multiple Myeloma 427Neoplasms, Plasma Cell 68Lymphoma, Mantle-Cell 66Lymphoma 65Recurrence 64Lymphoma, Non-Hodgkin 43Lymphoma, Follicular 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Leukemia, Myeloid, Acute 36Lymphoma, Large B-Cell, Diffuse 34Waldenstrom Macroglobulinemia 33Lymphoma, B-Cell, Marginal Zone 30Leukemia, Lymphocytic, Chronic, B-Cell 28Neoplasms 24Carcinoma, Non-Small-Cell Lung 24Immunoglobulin Light-chain Amyloidosis 23Leukemia 21Hodgkin Disease 17Lymphoma, B-Cell 14Burkitt Lymphoma 14Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Myelodysplastic Syndromes 13Lymphoma, Large-Cell, Anaplastic 13Hematologic Neoplasms 13Immunoblastic Lymphadenopathy 12Breast Neoplasms 12Mycosis Fungoides 11Lymphoma, T-Cell, Cutaneous 11Lymphoma, Large-Cell, Immunoblastic 11Congenital Abnormalities 11

Interventions

Cisplatin 7Cetuximab 5Radiotherapy 3Drug Therapy 3Resistance Training 2Radiotherapy, Intensity-Modulated 2Nutritional Status 2Hydroxyurea 2Fluorouracil 2Erlotinib Hydrochloride 2Bevacizumab 2zimberelimab 1temsirolimus 1pembrolizumab 1Valproic Acid 1Sirolimus 1Radiation 1Psychology, Positive 1Oncolytic Virotherapy 1Methods 1Immunoglobulin G 1Etoposide 1Docetaxel 1Disulfides 1Cyclophosphamide 1Cryosurgery 1Chemoradiotherapy 1Celecoxib 1Carboplatin 1CP protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pharyngeal Neoplasms × Bortezomib × Clear all
NCT01445405 2019-12-17

Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
3 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Pharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡